The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors

類似資料

• ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma
  著者:: Batlevi, Connie Lee, 等
  出版事項: (2016)
• Histone deacetylase inhibitors in Hodgkin lymphoma
  著者:: Buglio, Daniela, 等
  出版事項: (2010)
• The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines
  著者:: Lemoine, Manuela, 等
  出版事項: (2012)
• Expression of histone deacetylases in lymphoma: Implication for the development of selective inhibitors
  著者:: Gloghini, Annunziata, 等
  出版事項: (2009)
• The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism
  著者:: Buglio, Daniela, 等
  出版事項: (2010)